{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:22:45Z","timestamp":1791184965984,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/gme.0b013e31826560da","type":"journal-article","created":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T07:13:35Z","timestamp":1351235615000},"page":"162-168","source":"Crossref","is-referenced-by-count":163,"title":["Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer"],"prefix":"10.1097","volume":"20","author":[{"given":"Juliane","family":"Baumgart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneli Stavreus","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora Kunovac","family":"Kallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Sundstr\u00f6m","family":"Poromaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210211","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1020299707510","article-title":"Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.","volume":"76","author":"Anderson","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"R2-10-20210211","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.","volume":"365","year":"2005","journal-title":"Lancet"},{"issue":"suppl 6","key":"R3-10-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12325-011-0017-1","article-title":"Update on adjuvant hormonal treatment of early breast cancer.","volume":"28","author":"Lao Romera","year":"2011","journal-title":"Adv Ther"},{"key":"R4-10-20210211","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jnci\/djh060","article-title":"Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial.","volume":"96","author":"Ganz","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R5-10-20210211","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00042192-200103000-00006","article-title":"Factors related to sexual function in postmenopausal women with a history of breast cancer.","volume":"8","author":"Greendale","year":"2001","journal-title":"Menopause"},{"key":"R6-10-20210211","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.1998.16.2.501","article-title":"Life after breast cancer: understanding womens health-related quality of life and sexual functioning.","volume":"16","author":"Ganz","year":"1998","journal-title":"J Clin Oncol"},{"key":"R7-10-20210211","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.maturitas.2010.03.027","article-title":"Sexuality after breast cancer: a review.","volume":"66","author":"Emilee","year":"2010","journal-title":"Maturitas"},{"key":"R8-10-20210211","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.breast.2008.04.001","article-title":"The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions.","volume":"17","author":"Mok","year":"2008","journal-title":"Breast"},{"key":"R9-10-20210211","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1200\/JCO.1999.17.8.2371","article-title":"Predictors of sexual health in women after a breast cancer diagnosis.","volume":"17","author":"Ganz","year":"1999","journal-title":"J Clin Oncol"},{"key":"R10-10-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/brst.2001.0397","article-title":"The impact of endocrine therapy on patients with breast cancer: a review of the literature.","volume":"11","author":"Coster","year":"2002","journal-title":"Breast"},{"key":"R11-10-20210211","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1743-6109.2010.02034.x","article-title":"Sexual function after breast cancer.","volume":"8","author":"Panjari","year":"2011","journal-title":"J Sex Med"},{"key":"R12-10-20210211","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00001813-200409000-00003","article-title":"Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.","volume":"15","author":"Morales","year":"2004","journal-title":"Anticancer Drugs"},{"key":"R13-10-20210211","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.1999.17.9.2659","article-title":"Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study.","volume":"17","author":"Day","year":"1999","journal-title":"J Clin Oncol"},{"key":"R14-10-20210211","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","article-title":"Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer.","volume":"9","author":"Chin","year":"2009","journal-title":"Clin Breast Cancer"},{"key":"R15-10-20210211","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ctrv.2008.04.001","article-title":"The influence of endocrine treatments for breast cancer on health-related quality of life.","volume":"34","author":"Buijs","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"R16-10-20210211","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.bjc.6600294","article-title":"Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy.","volume":"86","author":"Mourits","year":"2002","journal-title":"Br J Cancer"},{"key":"R17-10-20210211","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.2001.19.7.1885","article-title":"Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials.","volume":"19","author":"Fallowfield","year":"2001","journal-title":"J Clin Oncol"},{"key":"R18-10-20210211","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","article-title":"Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.","volume":"22","author":"Fallowfield","year":"2004","journal-title":"J Clin Oncol"},{"key":"R19-10-20210211","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/13697130802244422","article-title":"A survey among breast cancer survivors: treatment of the climacteric after breast cancer.","volume":"11","author":"Antoine","year":"2008","journal-title":"Climacteric"},{"key":"R20-10-20210211","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1200\/JCO.2007.10.8274","article-title":"Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.","volume":"25","author":"Jones","year":"2007","journal-title":"J Clin Oncol"},{"key":"R21-10-20210211","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO.1999.17.5.1488","article-title":"Effect of tamoxifen on sexual functioning in patients with breast cancer.","volume":"17","author":"Mortimer","year":"1999","journal-title":"J Clin Oncol"},{"key":"R23-10-20210211","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1200\/JCO.2005.11.181","article-title":"Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.","volume":"23","author":"Whelan","year":"2005","journal-title":"J Clin Oncol"},{"key":"R24-10-20210211","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-006-9260-6","article-title":"Quality of life of postmenopausal women in the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years adjuvant treatment for early breast cancer.","volume":"100","author":"Cella","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"R25-10-20210211","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1006263818115","article-title":"Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.","volume":"55","author":"Fallowfield","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"R26-10-20210211","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2005.03.3654","article-title":"Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer.","volume":"24","author":"Fallowfield","year":"2006","journal-title":"J Clin Oncol"},{"key":"R28-10-20210211","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast canceris it safe), a randomised comparison: trial stopped.","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"R29-10-20210211","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.","volume":"100","author":"Holmberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R30-10-20210211","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"key":"R31-10-20210211","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"R32-10-20210211","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/13697137.2010.529967","article-title":"Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.","volume":"14","author":"Pfeiler","year":"2011","journal-title":"Climacteric"},{"key":"R35-10-20210211","first-page":"346","article-title":"Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.","volume":"101","author":"Parsons","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R36-10-20210211","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)56474-7","article-title":"Comparative study: Replens versus local estrogen in menopausal women.","volume":"61","author":"Nachtigall","year":"1994","journal-title":"Fertil Steril"},{"key":"R37-10-20210211","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/09513591003632258","article-title":"Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.","volume":"26","author":"Biglia","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"R39-10-20210211","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/EJE-07-0403","article-title":"A purification step prior to commercial sensitive immunoassay is necessary to achieve clinical usefulness when quantifying serum 17-estradiol in prepubertal children.","volume":"158","author":"Ankarberg-Lindgren","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"R40-10-20210211","first-page":"975","article-title":"Diurnal rhythm of testosterone secretion before and throughout puberty in healthy girls: correlation with 17-estradiol and dehydroepiandrosterone sulfate.","volume":"84","author":"Ankarberg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-10-20210211","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"R43-10-20210211","first-page":"63","article-title":"The 1996 Swedish sex survey. An introduction and remarks on changes in early sexual experiences.","volume":"1","author":"Helmius","year":"1998","journal-title":"Scand J Sexol"},{"key":"R44-10-20210211","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.2001.tb04012.x","article-title":"Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project.","volume":"949","author":"Day","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"R45-10-20210211","first-page":"559","article-title":"The effects of tamoxifen on the vaginal epithelium in postmenopausal women.","volume":"9","author":"Love","year":"2000","journal-title":"J Womens Health (Larchmt)"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GME.0b013e31826560da","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:40:51Z","timestamp":1620952851000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201302000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31826560da","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}